Consistently, oophorectomy to minimize estrogen production in human BRCA1 mutation carriers and in mouse carrying mammary-specific BRCA1 mutations significantly reduced the frequency of breast/mammary cancer formation [27, 28], whereas the administration of tamoxifen, which blocks E2/ERα signaling, reduced cancer risk [29–31]. The gene discussed is ESR1; the disease is breast cancer.